Treatment

Dapagliflozin clinical trials

Active studies that list Dapagliflozin as an intervention or treatment.

3active studies

1recruiting now

5countries represented

4largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 4

Chronic Kidney Disease(CKD)Condition

Dapagliflozin, SemaglutideTreatment

Denmark, Germany4 locations

Peter RossingSponsor

Updated 2025-11-20 · NCT07239570See eligibility →

Active, not recruitingPhase 2, Phase 3

Type 1 Diabetes MellitusCondition

Insulin, SemaglutideTreatment

United States1 locations

State University of New York at BuffaloSponsor

Updated 2026-05-29 · NCT03899402See eligibility →

Active, not recruitingPhase 2

Type2 DiabetesCondition

Semaglutide, DapagliflozinTreatment

Sweden1 locations

Region SkaneSponsor

Updated 2025-07-16 · NCT04451837See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.